220 related articles for article (PubMed ID: 25568212)
1. Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.
Buffone C; Schulte B; Opp S; Diaz-Griffero F
J Virol; 2015 Mar; 89(6):3285-94. PubMed ID: 25568212
[TBL] [Abstract][Full Text] [Related]
2. Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.
Schulte B; Buffone C; Opp S; Di Nunzio F; De Souza Aranha Vieira DA; Brandariz-Nuñez A; Diaz-Griffero F
J Virol; 2015 Aug; 89(16):8599-610. PubMed ID: 26063425
[TBL] [Abstract][Full Text] [Related]
3. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1.
Fricke T; White TE; Schulte B; de Souza Aranha Vieira DA; Dharan A; Campbell EM; Brandariz-Nuñez A; Diaz-Griffero F
Retrovirology; 2014 Aug; 11():68. PubMed ID: 25123063
[TBL] [Abstract][Full Text] [Related]
4. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
[TBL] [Abstract][Full Text] [Related]
5. MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.
Smaga SS; Xu C; Summers BJ; Digianantonio KM; Perilla JR; Xiong Y
Structure; 2019 Aug; 27(8):1234-1245.e5. PubMed ID: 31155311
[TBL] [Abstract][Full Text] [Related]
6. Mx oligomer: a novel capsid pattern sensor?
Kong J; Ma M; He S; Qin X
Future Microbiol; 2016 Aug; 11():1047-55. PubMed ID: 27492442
[TBL] [Abstract][Full Text] [Related]
7. MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells.
Opp S; Vieira DA; Schulte B; Chanda SK; Diaz-Griffero F
J Virol; 2015 Dec; 90(6):3056-64. PubMed ID: 26719253
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into HIV-1 restriction by MxB.
Fribourgh JL; Nguyen HC; Matreyek KA; Alvarez FJD; Summers BJ; Dewdney TG; Aiken C; Zhang P; Engelman A; Xiong Y
Cell Host Microbe; 2014 Nov; 16(5):627-638. PubMed ID: 25312384
[TBL] [Abstract][Full Text] [Related]
9. Naturally Occurring Mutations in HIV-1 CRF01_AE Capsid Affect Viral Sensitivity to Restriction Factors.
Nakayama EE; Saito A; Sultana T; Jin Z; Nohata K; Shibata M; Hosoi M; Motomura K; Shioda T; Sangkitporn S; Loket R; Saeng-Aroon S
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):382-392. PubMed ID: 29325426
[TBL] [Abstract][Full Text] [Related]
10. GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.
Xie L; Ju Z; Zhong C; Wu Y; Zan Y; Hou W; Feng Y
Virol Sin; 2021 Feb; 36(1):85-94. PubMed ID: 32632818
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid.
Kong J; Xu B; Wei W; Wang X; Xie W; Yu XF
Protein Cell; 2014 Dec; 5(12):954-7. PubMed ID: 25363729
[No Abstract] [Full Text] [Related]
12. Host and viral determinants for MxB restriction of HIV-1 infection.
Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
[TBL] [Abstract][Full Text] [Related]
13. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
14. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
15. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.
Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH
Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207
[TBL] [Abstract][Full Text] [Related]
16. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
17. The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
Buffone C; Kutzner J; Opp S; Martinez-Lopez A; Selyutina A; Coggings SA; Studdard LR; Ding L; Kim B; Spearman P; Schaller T; Diaz-Griffero F
Virology; 2019 May; 531():260-268. PubMed ID: 30959264
[TBL] [Abstract][Full Text] [Related]
18. The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB.
Liu Z; Pan Q; Liang Z; Qiao W; Cen S; Liang C
Retrovirology; 2015 Jan; 12():1. PubMed ID: 25571928
[TBL] [Abstract][Full Text] [Related]
19. MxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface.
Miles RJ; Kerridge C; Hilditch L; Monit C; Jacques DA; Towers GJ
Elife; 2020 Jun; 9():. PubMed ID: 32553106
[TBL] [Abstract][Full Text] [Related]
20. The interferon-inducible MxB protein inhibits HIV-1 infection.
Liu Z; Pan Q; Ding S; Qian J; Xu F; Zhou J; Cen S; Guo F; Liang C
Cell Host Microbe; 2013 Oct; 14(4):398-410. PubMed ID: 24055605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
